시장보고서

상품코드

2075895

이중특이성 단백질 키나아제 TTK 억제제 시장 : 제품 유형별, 용도별, 최종 사용자별, 지역별

Dual Specificity Protein Kinase TTK Inhibitor Market, By Product Type, By Application, By End User, By geography

발행일: 2026년 04월 | 리서치사: 구분자

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

가격

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,500

￦ 6,704,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 7,000

￦ 10,428,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,898,000

※ 부가세 별도

한글목차

영문목차

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

이중특이성 단백질 키나아제 TTK 억제제 시장은 2026년에 1억 4,110만 달러 규모로 추정되며, 2033년까지 5억 8,420만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 22.5%로 성장할 전망입니다.

분석 범위		분석 상세
기준 연도	2025년	시장 규모(2026년)	1억 4,110만 달러
실적 데이터	2020-2024년	예측 기간	2026-2033년
예측 기간 CAGR(2026-2033년)	22.50%	예측 금액(2033년)	5억 8,420만 달러

단백질 키나아제는 중요한 세포 과정에서의 촉매 활성과 신호 전달 기능에 있어 중요한 역할을 합니다. TTK(Monopolar spindle 1(Mps1)이라고도 함)는 티로신 및 세린/스레오닌 잔기 모두의 인산화를 유발하는 이중특이성 키나아제입니다. 이는 세포 주기 진행과 관련된 유사분열에서 중기판 위의 염색체 정렬을 촉진하는 방추체 조립 체크포인트(SAC) 중 하나입니다. TTK는 모든 염색체의 적절한 정렬, 나아가 유사분열 방추체에의 올바른 부착에 필수적입니다. 이 키나아제를 표적으로 삼음으로써, 유사분열 중인 염색체 분리를 효과적으로 억제할 수 있으며, 이는 암 치료 분야에서 획기적인 발견이 될 가능성이 있습니다.

시장 역학

1인당 의료비 증가로 인해 만성 질환 치료를 위한 연구 개발 활동이 활발해지고 있으며, 이는 예측 기간 동안 세계 이중특이성 단백질 키나아제 TTK 억제제 시장의 성장을 견인할 것으로 예측됩니다. 2019년 세계은행의 추산에 따르면, 라틴아메리카의 1인당 의료비는 크게 증가했습니다. 라틴아메리카의 의료 지출은 2016년에는 약 6억 3,800만 달러였으나, 2018년까지 6억 6,600만 달러로 증가했습니다.

규제 당국의 제품 출시 승인 건수 증가 역시 예측 기간 동안 시장 성장을 견인할 것으로 전망됩니다. 예를 들어, 2019년 1월, 대형 연구형 바이오의약품 기업인 Pfizer Inc.가 개발한 EGFR의 선택적 및 비가역적 억제제 다코미티닙은 EGFR 돌연변이 양성인 절제 불가능하거나 재발성 비소세포폐암(NSCLC)의 치료제로서 일본 후생노동성의 승인을 받았습니다.

본 조사의 주요 특징 :

본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로, 세계 이중특이성 단백질 키나아제 TTK 억제제 시장의 주요 기업 프로파일을 소개했습니다.
본 보고서에서 도출된 인사이트은 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있도록 돕습니다.
본 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계릐 이중특이성 단백질 키나아제 TTK 억제제 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 141.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	22.50%	2033 Value Projection:	USD 584.2 Mn

Protein kinases play an important role in the catalytic activity and signaling functional transduction of critical cellular processes. TTK, also called monopolar spindle 1 (Mps1), is a dual specificity kinase that causes the phosphorylation of both tyrosine and serine/threonine residues. It is one of the spindle assembly checkpoint (SAC) that facilitates the alignment of chromosomes on the metaphase plate in mitosis which is associated with the progression of the cell cycle. TTK is essential for the right alignment of all chromosomes, and subsequently, correct attachment to the mitotic spindle. Targeting this kinase may effectively block chromosome segregation during mitosis, and it could be a great invention for cancer therapy.

Market Dynamics

The increased per capita healthcare spending has enhanced research and development activities for the treatment of chronic diseases, which is expected to drive the global dual specificity protein kinase TTK inhibitors market growth over the forecast period. According to the World Bank estimates in 2019, the per capita healthcare expenditure increased significantly in Latin America. The healthcare expenditure in Latin America was around US$ 638 Mn in 2016, which increased to US$ 666 Mn by 2018.

Increasing approvals for product launches by the regulatory bodies is also expected to drive the market growth over the forecast period. For instance, in January 2019, Dacomitinib, a selective and irreversible inhibitor of EGFR by Pfizer Inc., a leading research-based biopharmaceutical company, received approval from the Ministry of Health, Labour and Welfare of Japan for the treatment of EGFR mutation-positive inoperable or recurrent non-small cell lung cancer (NSCLC).

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global dual specificity protein kinase TTK inhibitors market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bayer AG, Pfizer Inc., Boston Pharmaceuticals, Nerviano Medical Sciences S.R.L (Part of NMS group), and Servier Laboratories
Insights from this report would allow marketers and the management authorities of companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global dual specificity protein kinase TTK inhibitors market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dual specificity protein kinase TTK inhibitors market

Detailed Segmentation:

Global Dual Specificity Protein Kinase TTK Inhibitors Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
BAY 1217389
BOS-172722
CFI-402257
S 81694
Others
Global Dual Specificity Protein Kinase TTK Inhibitors Market, By Application (Revenue, USD Mn, 2021 - 2033)
Non-hematologic Malignancies
Breast Cancer
Prostate Cancer
Pancreatic Ductal Adenocarcinoma
Others
Global Dual Specificity Protein Kinase TTK Inhibitors Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- Product Type
  - BAY 1217389
  - BOS-172722
  - CFI-402257
  - S 81694
  - Others
- Application
  - Non-hematologic Malignancies
  - Breast Cancer
  - Prostate Cancer
  - Pancreatic Ductal Adenocarcinoma
  - Others
- By Country
  - U.S.
  - Canada
Latin America
- Product Type
  - BAY 1217389
  - BOS-172722
  - CFI-402257
  - S 81694
  - Others
- Application
  - Non-hematologic Malignancies
  - Breast Cancer
  - Prostate Cancer
  - Pancreatic Ductal Adenocarcinoma
  - Others
- By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Product Type
  - BAY 1217389
  - BOS-172722
  - CFI-402257
  - S 81694
  - Others
- Application
  - Non-hematologic Malignancies
  - Breast Cancer
  - Prostate Cancer
  - Pancreatic Ductal Adenocarcinoma
  - Others
- By Country
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Product Type
  - BAY 1217389
  - BOS-172722
  - CFI-402257
  - S 81694
  - Others
- Application
  - Non-hematologic Malignancies
  - Breast Cancer
  - Prostate Cancer
  - Pancreatic Ductal Adenocarcinoma
  - Others
- By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Product Type
  - BAY 1217389
  - BOS-172722
  - CFI-402257
  - S 81694
  - Others
- Application
  - Non-hematologic Malignancies
  - Breast Cancer
  - Prostate Cancer
  - Pancreatic Ductal Adenocarcinoma
  - Others
- By Country
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Product Type
  - BAY 1217389
  - BOS-172722
  - CFI-402257
  - S 81694
  - Others
- Application
  - Non-hematologic Malignancies
  - Breast Cancer
  - Prostate Cancer
  - Pancreatic Ductal Adenocarcinoma
  - Others
- By Region/Country
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Bayer AG
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
Boston Pharmaceuticals
Nerviano Medical Sciences S.R.L (Part of NMS group)
Servier Laboratories.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Recent Trends
Mergers, Acquisitions, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
PORTER's Analysis

4. Global Dual Specificity Protein Kinase Ttk Inhibitor Market, By Product Type, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
S 81694
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
BAY 1217389
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
BOS-172722
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
CFI-402257
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends

5. Global Dual Specificity Protein Kinase Ttk Inhibitor Market, By Application, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Non-hematologic Malignancies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
Pancreatic Ductal Adenocarcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends

6. Global Dual Specificity Protein Kinase Ttk Inhibitor Market, By End User, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends

7. Global Dual Specificity Protein Kinase Ttk Inhibitor Market, By Region, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
North America
- Market Size and Forecast,Y-o-Y Growth, By Product Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2021 -2033, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth, By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 -2033, (US$ Mn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast,Y-o-Y Growth, By Product Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2021 -2033, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth, By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 -2033, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast,Y-o-Y Growth, By Product Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2021 -2033, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth, By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 -2033, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast,Y-o-Y Growth, By Product Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2021 -2033, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth, By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 -2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Market Size and Forecast,Y-o-Y Growth, By Product Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2021 -2033, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth, By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 -2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast,Y-o-Y Growth, By Product Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2021 -2033, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth, By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country/Region, 2021 -2033, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Bayer AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Boston Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Nerviano Medical Sciences Srl
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Les Laboratoires Servier SAS
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Other Prominent Players.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
Analysts' Views

9. Section

References
Research Methodology
About us and Sales Contact

이중특이성 단백질 키나아제 TTK 억제제 시장 : 제품 유형별, 용도별, 최종 사용자별, 지역별